Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-16-764507
Filing Date
2016-11-09
Accepted
2016-11-09 17:09:32
Documents
2
Period of Report
2016-11-09

Document Format Files

Seq Description Document Type Size
1 FORM 6-K d274574d6k.htm 6-K 10375
2 EX-99.1 d274574dex991.htm EX-99.1 13253
  Complete submission text file 0001193125-16-764507.txt   24626
Mailing Address #1203-4464 MARKHAM STREET VICTORIA BC A1 V8Z 7X8
Business Address #1203-4464 MARKHAM STREET VICTORIA BC A1 V8Z 7X8 250-708-4272
Aurinia Pharmaceuticals Inc. (Filer) CIK: 0001600620 (see all company filings)

EIN.: 000000000 | State of Incorp.: A0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36421 | Film No.: 161985114
SIC: 2834 Pharmaceutical Preparations